Cronos Group Inc at Canaccord Genuity Global Cannabis Conference Transcript

May 18, 2023 / 03:00PM GMT
Matt Bottomley - Canaccord Genuity Inc. - Analyst

Everyone. So we've been chatting with a few of the Canadian LPs this morning, and it's something that a little bit different, I think, in the Cronos case is related to their balance sheet. I just wanted, I guess, to first introduce Michael Gorenstein, the CEO of Cronos Group, one of the original -- or is it OGs, what do they call them, but one of the first people I've met in this space actually.

Actually, Carl Merton's here, too. There's a few.

Michael Gorenstein - Cronos Group Inc. - Chairman, President, and CEO

All right.

Questions and Answers:

Matt Bottomley - Canaccord Genuity Inc. - Analyst

So anyways, thanks for joining us. And I think that maybe the first topic just to start with is a quick review of where the company is from a more fundamental standpoint and then some of the more juicier questions we got on balance sheet, where that may eventually get deployed, views on the US, things like that. So maybe the company fundamentals first, and then
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot